Quarterly ResultAug 6, 2026, 04:13 PM
Viatris Q2 Net Sales $3.75B, Reports Net Loss of $118.8M
AI Summary
Viatris Inc. reported Q2 2026 net sales of $3.75 billion, an increase from $3.57 billion in the prior year quarter, but recorded a net loss of $118.8 million, widening from a $4.6 million loss in Q2 2025. However, year-to-date net earnings significantly improved to $57.6 million compared to a $3.05 billion loss in the same period last year, largely due to the absence of a goodwill impairment charge. The company also announced an agreement to sell Tyrvaya® product rights for $30 million upfront, resulting in a $177.8 million intangible asset write-down, and continued to reduce long-term debt to $11.61 billion.
Key Highlights
- Q2 2026 net sales increased to $3.75 billion from $3.57 billion in Q2 2025.
- Q2 2026 net loss was $118.8 million, compared to a $4.6 million net loss in Q2 2025.
- Year-to-date net earnings were $57.6 million, a significant improvement from a $3.05 billion loss in 2025.
- Entered agreement to sell Tyrvaya® product rights for $30 million upfront, with a $177.8 million write-down.
- Long-term debt reduced to $11.61 billion from $12.48 billion at year-end 2025.
- Declared cash dividends of $0.12 per common share for the quarter.
- Repurchased $150.0 million of common stock during the quarter.
- Net cash provided by operating activities was $770.1 million for the six months.
Price Impact
More from VTRS